The Ulrich Group investigates genetic and lifestyle factors in the formation and prognosis of cancer with focus on colorectal cancer. In addition Dr. Ulrich focuses on prevention strategies with NSAIDs, with pharmacogenetics, nutrition, exercise and cancer, as well as connections between obesity, adipose tissue, and the progress of cancer.
Learn more about the Ulrich Group's research >>
Huntsman Cancer Institute’s Phyllis Pettit Nassi, MSW, attended a White House event where President Biden announced a relaunch of the Cancer Moonshot initiative. She talks about her work to reduce American Indian cancer disparities, which the Moonshot aims to address.... Read More
Neli Ulrich, PhD, MS, cancer center director at Huntsman Cancer Institute, shares some of the innovations and successes of the past year. Whether it’s a record number of patients involved with clinical trials or nearly $100 million received in grant funding, this is an exciting time for everyone. Learn about some of the new and creative ways, Huntsman Cancer Institute is having a profound, positive impact on the Mountain West. ... Read More
The ColoCare Study, a major international study of colorectal cancer, has received a five-year renewal and $10 million to fund colorectal cancer treatment innovations. This next phase of the project will use research findings from the ColoCare Study to develop new medical interventions.... Read More
